ReviewCancer management and research2020

Biomolecular Factors Represented by Bcl-2, p53, and Tumor-Infiltrating Lymphocytes Predict Response for Adjuvant Anthracycline Chemotherapy in Patients with Early Triple-Negative Breast Cancer.

Xenia Elena Bacinschi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.